Delivery Order SPE2DB22D1202-SPE2DB25FUXR3

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,084.84 Firm Fixed Price Delivery Order is for the supply of 4,567,903,519 units of Dexamethasone 4 mg tablets. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award with ID SPE2DB20D3103|SPE2DB24FP1K6 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,866.30 firm fixed-price delivery order is for the supply of 4 mg dexamethasone tablets. The contract has an ultimate completion date of June 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,285.33 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,262,613 units of the pharmaceutical product Dexamethasone 4 mg Tablet, 100s. This contract has a firm fixed price and an ultimate completion date of July 29, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,754.98 firm fixed-price delivery order is for the supply of 4,565,586,405 units of 20 mg/5 mL dexamethasone vials. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is a delivery order (SPE2DB23FN9C6) valued at $5,061.00, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,422 units of 4 mg dexamethasone tablets to support military healthcare programs. This contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 4,565,754,227 units of Dexamethasone 4 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $3,699.65 and a period of performance through September 11, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to...
This federal contract award, identified as SPE2DB22D3501|SPE2DB25FVH32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,959.36 firm fixed-price delivery order is for the supply of 4567944682 - DEXAMETHASONE 10 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of April 17, 2025 and was awarded on April 16, 2025. This delivery order is part of a larger...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,352,393 units of Dexamethasone 4mg tablets over a term ending on January 18, 2024. The potential value of the contract is $2,376.00. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts to provide...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,715.78, is for the delivery of dexamethasone 20 mg/5 ml vials with a final completion date of April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of 4,556,637,173 dexamethasone 6 mg tablets in lots of 100 to the Defense Logistics Agency (DLA). The $5,002.58 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 21, 2022, with a completion date of March 22, 2022. The contract is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUXR3
    Delivery Order

This federal contract award, SPE2DB22D1202|SPE2DB25FUXR3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,332.69 firm fixed-price delivery order is for 4,567,871,986 units of the medication Dexamethasone 4 mg tablet. The contract has an ultimate completion date of April 11, 2025 and does not utilize any set-aside designations, indicating open competition.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC), SPE2DX, with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 6:28 PM